Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus

被引:323
|
作者
Cui, LZ
Tominaga, E
Neoh, HM
Hiramatsu, K
机构
[1] Juntendo Univ, Fac Med, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Fac Med, Dept Infect Control Sci, Bunkyo Ku, Tokyo 1138421, Japan
关键词
D O I
10.1128/AAC.50.3.1079-1082.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We present here findings of a strong positive correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus (VISA). This correlation is related to cell wall thickening, suggesting that, similar to the case with vancomycin resistance in VISA, the physical barrier of a thickened cell wall may contribute to daptomycin resistance in S. aureus.
引用
收藏
页码:1079 / 1082
页数:4
相关论文
共 50 条
  • [41] Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
    Liang, Jin
    Hu, Yuanfang
    Fu, Mingxia
    Li, Na
    Wang, Fengxia
    Yu, Xiaojun
    Ji, Bing
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 379 - 388
  • [42] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    Fong, R. K. C.
    Low, J.
    Koh, T. H.
    Kurup, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (08) : 983 - 987
  • [43] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    R. K. C. Fong
    J. Low
    T. H. Koh
    A. Kurup
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28
  • [44] Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus
    Capin, Busra Betul Ozmen
    Tekeli, Alper
    Karahan, Zeynep Ceren
    MICROBIAL DRUG RESISTANCE, 2020, 26 (03) : 238 - 244
  • [45] Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus
    Hu, Jian
    Han, Xinjun
    Ma, Xiaoxue
    Chen, Xutao
    Zhou, Zhenping
    Peng, Peilan
    Yu, Zhao
    Hou, Yongzhi
    Han, Peiru
    Pang, Long
    Yang, Yali
    Xu, Jia
    Wu, Wenhui
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (01) : 203 - 208
  • [46] Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia
    Yun, Ji Hyun
    Chang, Euijin
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Kim, Sung-Han
    Choi, Sang-Ho
    Lee, Sang-Oh
    Kim, Yang Soo
    MICROBIOLOGY SPECTRUM, 2024, 12 (08):
  • [47] Comparative proteomic analysis of vancomycin-sensitive and vancomycin-intermediate resistant Staphylococcus aureus
    Jian Hu
    Xinjun Han
    Xiaoxue Ma
    Xutao Chen
    Zhenping Zhou
    Peilan Peng
    Zhao Yu
    Yongzhi Hou
    Peiru Han
    Long Pang
    Yali Yang
    Jia Xu
    Wenhui Wu
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 139 - 153
  • [48] Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus
    Swenson, Jana M.
    Anderson, Karen F.
    Lonsway, David R.
    Thompson, Angela
    McAllister, Sigrid K.
    Limbago, Brandi M.
    Carey, Roberta B.
    Tenover, Fred C.
    Patel, Jean B.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2013 - 2017
  • [49] Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia
    Khatib, Riad
    Jose, Jinson
    Musta, Adina
    Sharma, Mamta
    Fakih, Mohamad G.
    Johnson, Leonard B.
    Riederer, Kathleen
    Shemes, Stephen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) : 1594 - 1599
  • [50] Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure
    Lenhard, Justin R.
    Brown, Tanya
    Rybak, Michael J.
    Meaney, Calvin J.
    Norgard, Nicholas B.
    Bulman, Zackery P.
    Brazeau, Daniel A.
    Gill, Steven R.
    Tsuji, Brian T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1584 - 1591